AR104081A1 - ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES - Google Patents

ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES

Info

Publication number
AR104081A1
AR104081A1 ARP150103307A ARP150103307A AR104081A1 AR 104081 A1 AR104081 A1 AR 104081A1 AR P150103307 A ARP150103307 A AR P150103307A AR P150103307 A ARP150103307 A AR P150103307A AR 104081 A1 AR104081 A1 AR 104081A1
Authority
AR
Argentina
Prior art keywords
antibody molecules
join
disclosed
disorders
treat
Prior art date
Application number
ARP150103307A
Other languages
Spanish (es)
Inventor
Dranoff Glenn
Marie Mataraza Jennifer
Wen Chang Hwai
Johann Frey Gerhard
Helen Sharpe Arlene
James Freeman Gordon
Original Assignee
Novartis Ag
Dana Farber Cancer Inst Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Dana Farber Cancer Inst Inc, Harvard College filed Critical Novartis Ag
Publication of AR104081A1 publication Critical patent/AR104081A1/en

Links

Abstract

Se divulgan moléculas de anticuerpo que se unen específicamente a PD-L1. También se divulgan terapias de combinación que comprenden moléculas de anticuerpo anti-PD-L1. Las moléculas de anticuerpo anti-PD-L1 se pueden usar para tratar, prevenir y/o diagnosticar afecciones y trastornos cancerosos o infecciosos.Antibody molecules that specifically bind PD-L1 are disclosed. Combination therapies comprising anti-PD-L1 antibody molecules are also disclosed. Anti-PD-L1 antibody molecules can be used to treat, prevent and / or diagnose cancerous or infectious conditions and disorders.

ARP150103307A 2014-10-14 2015-10-13 ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES AR104081A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462063852P 2014-10-14 2014-10-14

Publications (1)

Publication Number Publication Date
AR104081A1 true AR104081A1 (en) 2017-06-28

Family

ID=59256454

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103307A AR104081A1 (en) 2014-10-14 2015-10-13 ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES

Country Status (1)

Country Link
AR (1) AR104081A1 (en)

Similar Documents

Publication Publication Date Title
ECSP17029218A (en) ANTIBODY MOLECULES THAT BIND AND USES PD-L1
ECSP16068976A (en) ANTIBODY MOLECULES THAT BIND AND USES PD-1
ECSP16081503A (en) ANTIBODY MOLECULES THAT BIND AND USES LAG-3
CR20160347A (en) ANTIBODY MOLECULES THAT JOIN TIM-3 AND USES OF THE SAME
CL2018001560A1 (en) Antibody molecules for pd-1 and their uses
ECSP19090538A (en) ANTIBODY MOLECULES THAT BIND AND USES CD73
CL2018001372A1 (en) Anti-april antibody molecules and uses thereof
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
BR112017013176A2 (en) chimeric antigen receptors and methods for using them
DOP2017000236A (en) NEUTRALIZATION OF CHIKUNGUNYA VIRUS MEDIATED BY ANTIBODIES
MX2020003783A (en) Antibody molecules to cd138 and uses thereof.
EA201700060A1 (en) THERAPEUTIC TOOL FOR CERATO-CONJUNCTIVE DISORDERS
AR104081A1 (en) ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES
CL2018001661A1 (en) Antibody molecules that bind to tnf alpha
AR119639A1 (en) ANTIBODY MOLECULES TO CD73 AND THEIR USES

Legal Events

Date Code Title Description
FB Suspension of granting procedure